# Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia

> **NCT04619693** · — · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 79 (actual)

## Conditions studied

- Pneumonia, Viral
- SARS-Cov-2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04619693
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-18
- **Primary completion:** 2021-10-06
- **Final completion:** 2021-10-06
- **Target enrollment:** 79 (ACTUAL)
- **Why stopped:** Difficulty of recruitment with the increase of the vaccination against COVID19
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04619693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04619693, "Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04619693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*